Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

BroadAMP-GPT effectively creates antimicrobial peptides to fight drug-resistant bacteria.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Baricitinib is the most effective treatment for alopecia areata.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Cyproterone and finasteride reduced hypersexuality but caused serious side effects.

Atrazine and finasteride disrupt hormone signaling and affect frog development.

Finasteride and dutasteride can cause severe, lasting side effects.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Baricitinib helps treat severe hair loss in people over 65.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

HIV-positive men who have sex with men have a higher rate of anal beta-papillomavirus infections.

Agaricus bisporus β-Glucan particles could effectively treat cervical cancer and offer antimicrobial and antioxidant benefits.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Alkaloids help fight influenza in animals but need more research for human use.

The drug combination was safe and showed promise in treating advanced tumors.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.